Page last updated: 2024-09-02

n(g)-iminoethylornithine and Cerebral Infarction, Middle Cerebral Artery

n(g)-iminoethylornithine has been researched along with Cerebral Infarction, Middle Cerebral Artery in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (66.67)29.6817
2010's1 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cao, L; Gao, Q; Jiang, T; Lu, J; Tan, L; Tan, MS; Wang, HF; Yu, JT; Zhang, QQ; Zhang, YD; Zhu, XC1
Connell, B; Saleh, TM; Wilson, BC1
Cheng, H; Fu, YT; Huang, SS; Hung, LM; Liu, HY; Nien, MW; Tsai, SK; Zhang, FB1

Other Studies

3 other study(ies) available for n(g)-iminoethylornithine and Cerebral Infarction, Middle Cerebral Artery

ArticleYear
Angiotensin-(1-7) induces cerebral ischaemic tolerance by promoting brain angiogenesis in a Mas/eNOS-dependent pathway.
    British journal of pharmacology, 2014, Volume: 171, Issue:18

    Topics: Angiogenesis Inhibitors; Angiotensin I; Angiotensin II; Animals; Brain; Cerebrovascular Circulation; Endostatins; Infarction, Middle Cerebral Artery; Male; Neovascularization, Physiologic; Nitric Oxide Synthase Type III; Ornithine; Peptide Fragments; Proto-Oncogene Mas; Proto-Oncogene Proteins; Rats, Sprague-Dawley; Receptors, G-Protein-Coupled

2014
Relaxin-induced reduction of infarct size in male rats receiving MCAO is dependent on nitric oxide synthesis and not estrogenic mechanisms.
    Neuroscience letters, 2006, Jan-30, Volume: 393, Issue:2-3

    Topics: Analysis of Variance; Animals; Brain Infarction; Drug Interactions; Enzyme Inhibitors; Estradiol; Estrogen Antagonists; Fulvestrant; Infarction, Middle Cerebral Artery; Male; Neuroprotective Agents; Nitric Oxide; Ornithine; Rats; Relaxin; Tetrazolium Salts

2006
Resveratrol neuroprotective effects during focal cerebral ischemia injury via nitric oxide mechanism in rats.
    Journal of vascular surgery, 2007, Volume: 46, Issue:2

    Topics: Animals; Brain; Brain Ischemia; Carotid Arteries; Disease Models, Animal; Dose-Response Relationship, Drug; Enzyme Inhibitors; Infarction, Middle Cerebral Artery; L-Lactate Dehydrogenase; Ligation; Male; Malondialdehyde; Middle Cerebral Artery; Neuroprotective Agents; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Ornithine; Rats; Rats, Long-Evans; Resveratrol; RNA, Messenger; Stilbenes; Up-Regulation

2007